Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

9 Monster Stock Market Predictions: Netflix Set To Bounce; Risk-Off Is On

Published 01/18/2022, 12:03 AM
Updated 09/20/2023, 06:34 AM

Stocks finished in mixed fashion on Friday, Jan. 14, with the indexes all plunging following the massive miss on the retail sales number. However, the indexes managed to rally back sharply into the close, resulting in the Invesco QQQ Trust (NASDAQ:QQQ)s finishing the day higher by around 60 bps and the SPX up around six bps.

S&P 500

The chart for the SPX is looking more and more like a diamond pattern. Additionally, the index has been directionless since Nov. 5, while a downtrend is starting to form, with a lower high, but to this point, there has been no lower low. There can’t be a downtrend until the S&P starts making lower lows. For that to happen, the index needs to fall below 4,500.

The RSI has been trending lower since that Nov. 5 timeframe, coupled with the price action, is a bearish divergence.

S&P 500 Index Daily Chart

5-Yr TIP

The 5-yr TIP Rate (Real Yield) pushed up, closing at -1.27%. It is getting to a significant resistance level of around -1.22%. If that resistance level breaks at -1.22%, then there is nothing to stop the real yield from rising to -50 bps, which will inflect a world of hurt on equity markets.

5-yr TIP Rate (Real Yield)

This week’s premium commentary noted that the changes in real yields and the S&P 500 earnings yield are highly correlated over the last five years. The further back in time one goes, the weaker the correlation gets. But in recent times, this has impacted the S&P 500.

An increase in the 5-yr tip of nearly 70 bps would push the S&P 500 earnings yield from its current 4.8% to 5.5%. It doesn’t seem like much, but that would cause the PE (NTM) to rise from 20.8 to around 18.1, or 15% lower, or 3960.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

S&P 500 Earnings Yied vs Real Yield

Apple

We will have to be on head-and-shoulders watch this week for Apple (NASDAQ:AAPL). The volume profile and the RSI all support the bearish reversal pattern. For confirmation, the stock needs to break support at $167.

Apple Daily Chart

Intuitive Surgical

Intuitive Surgical (NASDAQ:ISRG) formed a triple top pattern and all but confirmed it on Friday when the stock gapped below a crucial support level at $311. The sell-off could be steep, too, with its potential fall back to $270 if the stock does not rebound over $311 in the next few days.

Intuitive Surgical Daily Chart

Altria

Altria Group (NYSE:MO) looks like it may be trying to break out. If that’s the case, this one could rally to around $58.50.

Altria Group Daily Chart

Netflix

Netflix (NASDAQ:NFLX) will raise prices, and this announcement comes ahead of the company’s quarterly results this week. In my experience with Netflix, they raise prices ahead of earnings when they have substantial subscriber growth numbers. That could be the case again this time.

This stock is oversold currently and is due for a bounce. It could be a big bounce, too, probably to around $580.

Netflix Daily Chart

Roblox

Roblox (NYSE:RBLX) filled the gap at $77.70, and I’m hoping that is it for this one. I like this stock, and I bought it back in November. I have often likened this to Netflix in the early days, and I think it has that kind of growth potential. If the gap doesn’t prove to be support, a sturdy uptrend should also act as support.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Roblox Daily Chart

Block

Block (NYSE:SQ) (formerly known as Square) broke support on Friday at $133, and believe it or not, there is a slight gap that never filled around $115. It sounds crazy, but that is probably where the stock is heading. I still think this is overvalued from a fundamental perspective too. They should have just left the name Square.

Block Daily Chart

Biotech

If you can believe this, the SPDR® S&P Biotech ETF (NYSE:XBI) touched its February of 2020 levels before COVID. Not 2021, 2020. That is crazy. I hate to say it, but it has a gap to fill at $86, probably the ETF’s next stop.

Biotech ETF Daily Chart

Risk

Anyway, it is risk-off based on our Utilities Select Sector SPDR® Fund (NYSE:XLU)/XBI ratio, and based on that inverse Head And Shoulders pattern, it could be risk-off for a while.

XLU/XBI Daily Chart

Original Post

Latest comments

MO: RSI 74.31,overbought. MO is extended, buy on pullbacks.Accumulation still bullish.NFLX: Oversold, potential strangle candidate.Currently, stocks and markets are tradable, keeping stops close and taking profits.Commodities are leading and earnings season starts in earnest. Guidance is key.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.